A new discovery offers hope for ways to treat a debilitating disease that has become a leading cause of death in the US..

Researchers have found that a targeted therapy with tocilizumab reduced mortality by 30 percent for critically ill COVID-19 patients when administered within the first two days of ICU admission.

Doctors haven't had a good way to image early inflammation, but tests with mice suggest a new agent could improve things. It could even work on COVID-19.

Doctors haven't had a good way to image early inflammation, but tests with mice suggest a new agent could improve things. It could even work on COVID-19.

"Why do some people generate this very profound response, especially elderly people or people with underlying health conditions?" New research may explain.

"Why do some people generate this very profound response, especially elderly people or people with underlying health conditions?" New research may explain.

A Harvard Chan School study has found a link between optimism and hypertension, describing the positive force as having a “protective effect” on individuals, including those in combat.

"Toe spring" shoes may give the muscles in your feet a break—but that might not be a good thing in the long run.

"We thought that the molecule would decrease inflammation, but we were surprised to see that it could provide more protection at the same time."

A new medication made from a compound in turmeric shows promise in treating uveitis, an eye inflammation condition, in dogs. Can it work for people?